Series: Emerging Therapies for Moderate-to-Severe Atopic Dermatitis in Children
Moderate-to-severe atopic dermatitis is associated with negative impacts on quality of life and health outcomes in all age groups, with the impact on children and families being uniquely severe. However, the rapid pace of drug development and uncertainty around novel medications may impact the shared decision-making process and lead to the suboptimal treatment of many children. Thus, educating pediatric dermatologists and allergists is critical to positively affect treatment decisions and improve long-term outcomes. In addition, engaging experts in pediatric dermatology and allergy to consider what are the most important research issues in atopic dermatitis is important to direct future efforts. To address this need and help fill the gap left by canceled conferences in 2020, PeDRA is conducting a six-part educational series Emerging Therapies for Moderate-to-Severe Atopic Dermatitis in Children.
Webinars
Podcasts
Lawrence Eichenfield, MD
Program Chair
Professor of Dermatology and Pediatrics
Chief, Pediatric and Adolescent Dermatology
Vice Chair, Department of Dermatology
University of California, San Diego and Rady Children’s Hospital, San Diego
Megha Tollefson, MD
Program Presenter
Professor of Pediatrics and Dermatology, Mayo Clinic Rochester
Wynnis Tom, MD
Program Presenter
Associate Professor of Dermatology, University of California, San Diego
Dawn Davis, MD
Program Presenter
Professor of Dermatology and Pediatrics, Mayo Clinic Rochester
Emma Guttman Yassky, MD, PhD
Program Presenter
Professor of Dermatology and Immunology, Icahn School of Medicine at Mount Sinai
Bob Geng, MD
Program Presenter
Assistant Clinical Professor, University of California, San Diego
Eric Simpson, MD
Program Presenter
Professor of Dermatology, Oregon Health & Science University
Charlene Miciano
Patient Presenter
Korey Capozza, MPH
Program Presenter
Executive Director, Global Parents for Eczema Research
Sarah Pry
Parent Presenter
Wendy Smith-Begolka, MBS
Program Presenter
Sr, VP Scientific and Clinical Affairs, National Eczema Association